Tuesday Conference Approach to Thrombocytopenia Selim Krim, MD Assistant Professor TTUHSC.

Slides:



Advertisements
Similar presentations
Heather D. Mannuel, MD, MBA March 12, 2008
Advertisements

Michael F. McNamara, DO Sanford Maternal Fetal Medicine.
Platelet count.
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
HAEMATOLOGY MODULE: COAGULATION DISORDERS 1 Adult Medical-Surgical Nursing.
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
The HITS Keep Coming Marc J. Kahn, MD, MBA, FACP Peterman-Prosser Professor Tulane University School of Medicine New Orleans, LA.
Polycythemia Group C: Melanie, Michele, Sarah.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Case Discussion Huang Honghui Department of Hematology Ren Ji Hospital.
Zehra Eren, M.D.. explain hypertansion and renal disease interaction, describe renovascular diseases describe diagnostic evaluation explan therapy in.
HEPARIN INDUCED THROMBOCYTOPENIA GALILA ZAHER MBB ch, dip C Path, MRC Path.
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Volume 359: November 6, 2008 Number 19November 6, 2008.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
1-Gestetional Thrombocytopenia.
Anticoagulant therapy in RPL Dr. Z. Heidar Assistant professor SBMU.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Heparin-Induced Thrombocytopenia (HIT)
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura: prospective cohort study Cindy E. Neunert 1,2, George R. Buchanan 1,2,
Venous Thromboembolism
To Clot Or Not To Clot… Emergency Care for Coagulation Disorders/Conditions Rebecca Goldsmith Pediatric Thrombosis/Hemophilia Nurse McMaster Children’s.
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN DIAGNOSIS.
Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated.
HIV and haematology Mike Webb Division of Clinical Haematology 8 Feb 2010.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Treatment of urinary tract infections
Thrombotic Thrombocytopenic Purpura (TTP)
1 Presented by Martin Cohen, M.D. at the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee.
Platelet Transfusions Indications, dose and administration
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Hematology Block: Overview and Advice Tim Boswell, M4 Presentation created on 3/21/16.
Treatment and Prevention of Heparin- Induced Thrombocytopenia Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Types of Apheresis Blood taken from a healthy donor can be separated into its component parts during blood donation, where the needed component is collected.
Done by : Ahmed Fahad Basilim clinical pharmacist intern Supervised by: Dr. Muna Filfilan.
Heparin-Induced Thrombocytopenia Farzaneh Dastan Assistant Professor of Pharmacotherapy, Pharm D, BCPS SBMU.
Clinicopathological Case Conference of Haematological Medicine
Multiple choice questions
NEONATAL IMMUNE THROMBOCYTOPENIA
Antiphospholipid Antibody Syndrome
Thrombocytopenia Allen Chang, PGY2 5/18/15.
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Copyright © 2003 American Medical Association. All rights reserved.
Platelets disorders.
Autoimmune disease in pregnancy
David A. Terrero Salcedo, MD, Maria A
Approach to Thrombocytopenia
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
The Fascinating World of Haemostasis and Thrombosis
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
How I treat catastrophic thrombotic syndromes
Immune thrombocytopenic purpura (ITP)
When is HIT Really HIT? The Annals of Thoracic Surgery
Thrombophilia in pregnancy: Whom to screen, when to treat
How I treat heparin-induced thrombocytopenia and thrombosis
Thrombocytopenia in pregnancy
Presentation transcript:

Tuesday Conference Approach to Thrombocytopenia Selim Krim, MD Assistant Professor TTUHSC

Case 1 A 35-year-old woman is hospitalized for recurrent thrombophlebitis and a pulmonary embolus and is started on heparin.A 35-year-old woman is hospitalized for recurrent thrombophlebitis and a pulmonary embolus and is started on heparin. Two weeks earlier, she had completed a 6- month anticoagulation therapeutic regimen. A CBC on day 5 of her hospitalization shows a platelet count of 70,000/mm3.Two weeks earlier, she had completed a 6- month anticoagulation therapeutic regimen. A CBC on day 5 of her hospitalization shows a platelet count of 70,000/mm3.

MCQ 1 Which of the following is NOT associated with thrombocytopenia? Which of the following is NOT associated with thrombocytopenia? Thrombotic thrombocytopenia purpuraThrombotic thrombocytopenia purpura Immune thrombocytopenic purpuraImmune thrombocytopenic purpura Heparin induced thrombocytopeniaHeparin induced thrombocytopenia CirrhosisCirrhosis Polycythemia veraPolycythemia vera

MCQ 2 Which is NOT associated with TTP? Which is NOT associated with TTP? Megaloblastic anemiaMegaloblastic anemia FeverFever Central nervous system signsCentral nervous system signs ThrombocytopeniaThrombocytopenia Renal dysfunctionRenal dysfunction

MCQ 3 Which drug has NOT been implicated as a possible cause of TTP? Which drug has NOT been implicated as a possible cause of TTP? TiclopidineTiclopidine CyclosporineCyclosporine TacrolimusTacrolimus QuinineQuinine FluorouracilFluorouracil

MCQ 4 Which is INCORRECT about ITP? Which is INCORRECT about ITP? It is as common in children as it is in adultsIt is as common in children as it is in adults It occurs more in adults men than in adult womenIt occurs more in adults men than in adult women It can be secondary to other diseasesIt can be secondary to other diseases A bone marrow is not required for all patientsA bone marrow is not required for all patients Evans syndrome describes a combination of hemolytic anemia with ITPEvans syndrome describes a combination of hemolytic anemia with ITP

MCQ 5 Which treatment is NOT indicated for ITP? Which treatment is NOT indicated for ITP? Corticosteroids Corticosteroids Intravenous immunoglobulin Intravenous immunoglobulin Plasmapheresis Plasmapheresis Anti-D immune globulin Anti-D immune globulin Splenectomy Splenectomy

MCQ 6 Which of the following patient populations has the highest risk of HIT (assume all are receiving the same dose of heparin)? Which of the following patient populations has the highest risk of HIT (assume all are receiving the same dose of heparin)? After general surgeryAfter general surgery Hospitalized pediatric patientsHospitalized pediatric patients After orthopedic surgeryAfter orthopedic surgery Hospitalized general internal medicine patientsHospitalized general internal medicine patients Hospitalized obstetric patientsHospitalized obstetric patients

MCQ 7 Which is least suggestive of HIT? Which is least suggestive of HIT? Platelet count<20,000/ mm3 Platelet count<20,000/ mm3 Venous thrombosis Venous thrombosis Arterial thrombosis Arterial thrombosis Low molecular-weight heparin use within the previous week Low molecular-weight heparin use within the previous week Abnormal serotonin release assay Abnormal serotonin release assay

MCQ 8 How should one monitor for HIT in patients receiving heparin after undergoing orthopedic surgery? How should one monitor for HIT in patients receiving heparin after undergoing orthopedic surgery? Daily platelet countsDaily platelet counts Platelet counts every other day from day 4 to 14 of heparin treatmentPlatelet counts every other day from day 4 to 14 of heparin treatment Platelet counts at days 7 and 14 of heparin treatmentPlatelet counts at days 7 and 14 of heparin treatment Antibody levels for all patients at day 14 of therapyAntibody levels for all patients at day 14 of therapy Never unless thrombosis is suspectedNever unless thrombosis is suspected

MCQ 9 Which is NOT considered important in the initial treatment of HIT type II? Which is NOT considered important in the initial treatment of HIT type II? Discontinuation of all heparinDiscontinuation of all heparin Avoidance of warfarinAvoidance of warfarin Initiation of ArgatrobanInitiation of Argatroban Initiate aspirin therapyInitiate aspirin therapy

Key Points Consider TTP if the following pentad is met: fever, renal failure, thrombocytopenia, CNS involvement, and microangiopathic hemolytic anemia.Consider TTP if the following pentad is met: fever, renal failure, thrombocytopenia, CNS involvement, and microangiopathic hemolytic anemia. ITP is more common in females and equally affects children and adults.ITP is more common in females and equally affects children and adults. HIT is most often encountered in orthopedic patients taking heparin.HIT is most often encountered in orthopedic patients taking heparin.

Key Points HIT can cause a coagulopathy with venous or arterial thrombi.HIT can cause a coagulopathy with venous or arterial thrombi. If HIT occurs, all heparin products should be discontinued and a non-heparin, non- warfarin anticoagulant should be initiated.If HIT occurs, all heparin products should be discontinued and a non-heparin, non- warfarin anticoagulant should be initiated. In HIT alternative anticoagulation should continue for at least 2 weeks after heparin has been discontinued.In HIT alternative anticoagulation should continue for at least 2 weeks after heparin has been discontinued.

Thank You